What AK Medical Holdings Ltd. does

AK Medical Holdings Ltd. (HK: 01789.HK) is a China-headquartered orthopedic medical device company founded in 2003 and listed on the Hong Kong Stock Exchange since 2017. The company develops, manufactures, and markets joint replacement, spine, trauma, and tumor reconstruction implants, holding the #1 market share in China's artificial joint sector and a top-10 position globally in hip joint market share. AK Medical built its position by being the first company globally to commercialize metal additive manufacturing (3D printing) for orthopedic implants, anchored on four technology platforms: 3D ACT (bone-like trabecular structure construction), Supravit VPS plasma-sprayed HA coating (inherited from JRI Orthopaedics, 33 years of clinical application), VTS/IBot surgical navigation and robotics, and ICOS (Innovative Custom Orthopedic Solution) end-to-end personalized implant customization.

The company's product portfolio spans standardized implants (CL, ML, A3 knee, AKUKA unicompartmental, 3D ACT spinal fusion) and customized solutions (TCBridge long-bone defect repair, GPS II pelvic tumor reconstruction, AiTAR ankle replacement). Digital surgery products include the K3/K3+ intelligent surgical robot and VTS visualization system. AK Medical operates three manufacturing bases (Beijing Changping, Jiangsu Changzhou with 300K sets/year capacity, and Sheffield UK via JRI) plus R&D centers in Beijing, Shanghai, and the UK, and serves 7,500+ medical institutions across 40+ countries. Cumulative implant volume exceeds 1.2 million units globally.

Revenue is generated primarily through hardware sales of orthopedic implants and digital surgery systems, supplemented by professional training services via AK Academy. Go-to-market combines direct hospital sales via medical representatives in China, the JRI Orthopaedics subsidiary for UK/Europe, and distributor networks for other international markets. The company invests heavily in clinical KOL engagement through AAOS, CMEF, IAIAS, and the Belt and Road International Healthcare Exchange Program, with strategic R&D partnerships anchored by Peking University Third Hospital, Beijing Jishuitan Hospital, Imperial College London, and the University of Cambridge.

Name

AK Medical Holdings Ltd.

Legal name

爱康医疗控股有限公司 (AK Medical Holdings Limited)

Website

https://ak-medical.net

Company type

Public

Founded year

2003

Operating status

Operating

Headcount range

11–50 employees

Short description

AK Medical Holdings Ltd. is a Hong Kong-listed Chinese orthopedic medical device company that develops and manufactures 3D-printed joint replacement, spine, trauma, and tumor implants, holding the #1 share in China's artificial joint market and serving 7,500+ medical institutions across 40+ countries.

Ownership category

akta.pro rank

Product category

Orthopedic Implants and Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112), Medical Equipment and Supplies Manufacturing (3391), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle) (HLAHAEAA)

akta.pro secondary industries

Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine) (HLAHAEAL), Surgical Robotics & Computer-Assisted Surgery Platforms (HLAHADAF), Medical & Dental 3D Printing Services (patient-specific devices, dental labs) (IMAAADAG)

Keywords

• Orthopedic implants
• 3D printed medical devices
• Joint replacement systems
• Surgical navigation robots
• Personalized orthopedic solutions

Headquarters

HQ city

Beijing

HQ country

China

HQ region

Asia

Offices8 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Infrastructure

Revenue model

1. Orthopedic Implants and Prostheses: Sale of standardized and customized orthopedic implants including hip, knee, spine, trauma, and tumor products. Major revenue driver with products used in 7,500+ medical institutions globally.
2. Professional Training and Education: AK Academy provides orthopedic training programs, international exchange programs, and continuing education for surgeons. Revenue from training services and certification programs.
3. Digital Surgery Solutions: Sale and service of surgical navigation systems (VTS) and robotic surgical equipment (K3/K3+ robot) including software licenses and post-sale technical support.

Go-to-market motion3 records

Distribution channels3 records

Marketing channels8 records

Core offering

AK Medical is an international orthopedic industry group that designs, manufactures, and sells orthopedic implants and digital surgical solutions. Its core products include 3D-printed hip, knee, spine, trauma, and tumor implants built on four proprietary technology platforms (3D ACT, VPS coating, VTS/IBot navigation and robotics, and ICOS personalized customization). The company also markets surgical robots (K3/K3+) and navigation systems (VTS) for joint replacement procedures.

Product overview

AK Medical Holdings Ltd. is a global orthopedic industry group specializing in R&D, manufacturing, and marketing of orthopedic implants. The company operates a platform-based model centered on four technology platforms: 3D ACT (metal additive manufacturing), Supravit® VPS coating, VTS/robot navigation, and ICOS (customized orthopedic solutions). Product portfolio spans hip systems (CL, ML, SR II, ABM, VITA femoral stem), knee systems (A3, AKUKA unicompartmental, ACCK, AHK, 3D printed tibial platform), spine and trauma products (3D ACT spinal fusion, ORION, ARC, APOLLO, cervical/thoracic fixation systems), and tumor reconstruction (AMRS, GPS II, THS, TCBridge). The digital offerings include K3/K3+ surgical robots, VTS visualization navigation system, and ICOS doctor-engineer interaction platform enabling personalized surgical planning. Recent launches include AiTAR ankle replacement system (2026), expanding from large joints to small joints.

Differentiator

Problem solved

Functional benefit

Brands

• ICOS (Innovative Custom Orthopedic Solution): Total process personalized orthopedic diagnosis and treatment technology platform
• 3D ACT (3D Accurate Constructive Technology)
• VTS (Visual Treatment Solution)
• K3/K3+ Surgical Robot
• AK Institute
• INIXIO International R&D Center

Products and services

• AiTAR Total Ankle Replacement System (AiTAR全踝关节置换系统) China's first metal 3D printed ankle prosthesis using proprietary 3D ACT technology with trabecular-like porous structure for enhanced bone integration, targeting ankle joint replacement procedures.
• K3+ Intelligent Surgical Robot (K3+智能手术机器人) Intelligent surgical robot for knee replacement surgery with upgraded 3+3 axis self-developed robotic arm, featuring preoperative precise osteotomy planning, prosthesis matching, and soft tissue balancing for knee joint replacement.
• K3 Intelligent Surgical Robot (K3智能手术机器人) Surgical robot for knee replacement surgery with 3+3 axis self-developed robotic arm, featuring preoperative planning, real-time navigation, and precise bone cutting for improved surgical accuracy.
• VTS Visual Treatment Solution (VTS可视化智能辅助系统) Surgical navigation and visualization system for total hip arthroplasty providing intelligent preoperative planning and real-time intraoperative tracking with 3ms ultra-low latency.
• ICOS (Innovative Custom Orthopedic Solution) Digital orthopedic platform covering full year segments and all orthopedic subspecialties, enabling surgeon-engineer interaction for personalized surgical planning, custom implant design, intelligent manufacturing, and integrated digital solutions.
• A3 Knee System (A3膝关节系统) Primary knee replacement system with multiple constraint levels and implant types, featuring anatomical adaptation and high flexion up to 145 degrees.
• CL Hip System (AK-CL髋关节系统) Primary hip system featuring 3D printing innovation with hydroxyapatite coating and 3D ACT bone-like trabecular surface for enhanced osseointegration.
• VITA Femoral Stem (VITA股骨柄) Collaboration with JRI Orthopaedics - China's first short stem combining collar and triple-taper design, featuring Supravit HA coating for minimally invasive direct anterior approach.
• TCBridge Long-Segment Bone Defect Repair System (TCBridge创伤定制长段骨缺损修复系统) China's first NMPA-approved metal 3D printed customized long-segment bone defect repair prosthesis developed with Peking University Third Hospital.
• 3D ACT Spinal Fusion System (3D ACT脊柱融合系统) Spinal fusion products with high porosity, large pore structure, and bone-like elastic modulus for superior osseointegration in spine surgery.
• Metal 3D Printed Tibial Platform System (金属3D打印胫骨平台系统) China's first metal 3D printed tibial platform for primary knee replacement, pioneering 3D printing application in the knee joint sector.
• GPS II Universal Pelvic Tumor Reconstruction System (GPS II通用骨盆肿瘤重建系统) 3D printed tumor reconstruction system for pelvic tumor resection, adaptable to multiple tumor zones (I+II, II, II+III, I+II+III).
• AKUKA Unicompartmental Knee System (AKUKA单髁系统) Unicompartmental knee replacement system with fixed bearing (AFK) and mobile bearing (AMK) options, featuring cross-linked polyethylene insert.
• Patient-Matched Metal Locking Plate System & 3D-Printed Self-Stabilizing Artificial Vertebral Body System (患者匹配式金属锁定接骨板系统 & 3D打印自稳型人工椎体系统) Patient-matched orthopedic implant systems covering trauma and spine applications, completing the full orthopedic patient-matched product portfolio across joints, spine, trauma, bone tumors, and long bone defect repair.

Quantifiable outcome

• One AK prosthesis implanted every 2 minutes globally
• +3 more outcomes

Named customers6 records

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature5 records

Partnerships

Eight partnerships are on record, tiered core, strategic and minor.

• Beijing University Third Hospital (Peking University Third Hospital)coreStrategic or Co-development Partner · 2 April 2026Strategic R&D partnership for orthopedic implant development. Signed technology transfer agreement for spinal series technology (围脊柱系列技术). Joint development of VTS navigation system, ICOS platform, and biomechanical adaptation prostheses (Osteo Match). Collaboration on Beijing Natural Science Foundation projects since 2020.
• ADDLIFEstrategicChannel Partner/ Reseller/ Distributor · 25 November 2024Key business partner of JRI in European market. Delegation visit in November 2024 to strengthen partnerships. Discussed orthopedic 3D printing technology, medical engineering interaction, and intelligent orthopedic surgical equipment cooperation.
• Beijing Jishuitan HospitalcoreStrategic or Co-development Partner · 22 February 20233D Printing Joint Laboratory established under National Orthopedic Medical Center. Joint development of personalized products for trauma, joints, spine, and extremities. Collaborative clinical research and product registration. Provided personalized clinical solutions for approximately 500 complex patients.
• Imperial College LondonstrategicTechnology or IntegrationINIXIO international R&D center collaboration on cutting-edge research including orthopedic implant surface modification, drug delivery, osteoblast-forming factors, and next-generation implant development.
• University of CambridgestrategicTechnology or IntegrationINIXIO collaboration on advanced materials research for orthopedic implants including surface modification technologies and novel biomaterials.
• Kings College London HospitalstrategicTechnology or IntegrationINIXIO international R&D partnership for clinical research and new product development supporting European market entry.
• Beijing Friendship Hospital affiliated with Capital Medical UniversityminorStrategic or Co-development PartnerPATHWAYS Belt and Road International Healthcare Exchange Program partner for orthopedic surgeon training.
• Wang Jing Hospital of CACMSminorStrategic or Co-development PartnerBelt and Road International Healthcare Exchange Program partner for joint replacement training and academic exchange.

Scale indicators10 records

Recent moves7 records

Expansion highlights6 records

Emerging players

• THINK Surgical: Pure-play orthopedic surgical robotics company (TSolution One, TMINI) competing specifically in robotic-assisted knee replacement where AK's K3/K3+ targets; technology overlap rather than geographic overlap.
• 4WEB Medical: US-based pioneer of 3D-printed orthopedic truss implants for spine and extremities; directly comparable to AK's 3D ACT additive-manufacturing approach and patient-specific implant strategy.

Broad incumbents

• Johnson & Johnson DePuy Synthes: Largest orthopedic franchise globally through DePuy Synthes; competes broadly across joints, spine, and trauma where AK plays, with the Velys surgical robot adding to its robotics posture versus AK's K3.

Regional players

• Lepu Medical: Large diversified Chinese medical device company with an orthopedic implants and interventional franchise; comparable to AK in operating in China, navigating VBP, and competing in joint/spine segments domestically.

Direct peers

• MicroPort Scientific (MicroPort Orthopedics): China-headquartered orthopedic competitor with a hip/knee/spine portfolio and direct head-to-head rivalry with AK in China's VBP-driven artificial joint market; comparable scale and business model to AK in the Chinese orthopedic segment.
• Stryker: Global #1 orthopedic implant franchise and maker of the Mako surgical robot; directly competes with AK across hip/knee implants and surgical robotics, and is the global benchmark AK's K3 platform benchmarks against.
• Smith+Nephew: Global orthopedic and sports medicine player with the CORI handheld surgical robot and Journey knee system; competes with AK in robotics, knee, and hip implants across Europe, US, and emerging markets.
• Zimmer Biomet: Top-3 global orthopedic implant company with the Rosa robotics platform and Persona knee / Oxford partial knee systems; directly competes in the same surgical robotics, hip, and knee categories as AK Medical.
• Waston Medical: Chinese orthopedic implant maker (spine, trauma, joint) directly competing against AK in domestic tenders and VBP; same regulatory environment and hospital sales motion in China.
• Globus Medical: Specialized in spine, orthopedic trauma, and the ExcelsiusGPS surgical robotics platform; comparable to AK in surgical robotics and spine/trauma implant categories where AK's 3D ACT spinal fusion and trauma products compete.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/profile.phpid=100066565087327
• LinkedInlinkedin.com/company/akmedical

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries4 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AK Medical Holdings Ltd.